Skip to main content

Table 3 Adverse events during peptide vaccination

From: A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

 

Grade 1

Grade 2

Grade 3

Total

Injection site reaction

73

24

13

43

Constitutional symptoms

    

  Bone pain

16

14

13

43

  Appetite loss

29

5

1

35

  Fatigue

23

11

0

34

  Edema peripheral

10

3

0

10

Blood/bone marrow

    

  Lymphocytopenia

17

13

5

35

 Anemia

7

7

16

30

  White blood cell count decreased

6

6

5

17

Laboratory

    

  Hypoalbuminemia

27

13

0

40

  ALP increased

20

8

6

34

  AST increased

24

4

1

29

  Hyponatremia

24

1

0

25

  ALT increased

13

2

1

16

  Blood triglycerides increased

10

2

0

12

  Creatinine increased

6

1

2

8